Connect Sign In
LabMind podcasts
|
November 19, 2024 |
A New Edition of Magnify Is Available and Focuses on the FDA’s Rule To Regulate Lab-Developed Tests This edition features interviews with company leaders describing ARUP’s approaches to comply with the FDA’s rule and a video about how ARUP helped a family on a rare disease diagnostic journey. |
Michelle Tarver, MD, PhD, director of the FDA’s Center for Devices and Radiological Health (CDRH), and Jeff Shuren, MD, JD, CDRH director emeritus, appeared virtually at the Utah Life Sciences Summit. |
November 18, 2024 | FDA leaders answered questions on artificial intelligence (AI), international regulations, and representation in clinical trials during the Utah Life Sciences Summit. |
Ryan Nelson, PharmD, medical director of Precision Medicine at ARUP, was presented with a Double Helix Award by the American Society of Pharmacovigilance (ASP). |
November 15, 2024 |
ARUP Medical Director Ryan Nelson, PharmD, Receives a STRIPE Double Helix Award Ryan Nelson, PharmD, received a Double Helix Award for his work on MetaCensus during the Standardizing Laboratory Practices in Pharmacogenomics (STRIPE) Annual Meeting and Consensus Workshop. |
Laboratory tests, including those for fluid biomarkers, play a critical role in diagnosing and treating Alzheimer's disease. |
November 6, 2024 |
ARUP Consult Includes Updated Information on Biomarker Testing for Alzheimer’s Disease Diagnosis Laboratory tests, including those for fluid biomarkers, may be used to diagnose Alzheimer's disease. ARUP Consult details using such tests to help clinicians order the right test at the right time. |
Carl Wittwer, MD, PhD, with the LightCycler® he invented in the 1990s. |
October 29, 2024 |
Longtime ARUP Medical Director Carl Wittwer, MD, PhD, Receives Lifetime Achievement Award The University of Utah Licensing and Technology Office awards recognize impactful research and innovation. Though retired, Wittwer is active in advancing molecular diagnostics and mentoring others. |
ARUP Laboratories and Augurex Life Sciences Corp. are partnering to incorporate a 14-3-3η test that will aid in the early detection and management of rheumatoid arthritis. |
October 21, 2024 |
Augurex Announces Agreement With ARUP To Expand Access to Advanced Rheumatoid Arthritis Diagnosis ARUP Laboratories is partnering with Augurex Life Sciences Corp. to include the 14-3-3η test in the ARUP test menu to enhance the early detection of rheumatoid arthritis. |
ARUP Institute for Research and Innovation in Diagnostic and Precision Medicine™ We accelerate the development and adoption of cutting-edge diagnostic and prognostic technologies advancing patient care through groundbreaking science and engineering. The Sherrie Perkins Research and Innovation Collaboration Grant The Sherrie Perkins Research and Innovation Collaboration Grant funds cutting-edge research in laboratory medicine.
ARUP Newsroom
Live Chat